Mount Sinai Transplant Center

Mount Sinai Transplant Center
Name	Mount Sinai Transplant Center
Org	Icahn School of Medicine at Mount Sinai
Location	New York City, Manhattan
Country	United States
Type	Teaching hospital, transplant center
Beds	1,171
Founded	1852 (Mount Sinai Hospital)

Mount Sinai Transplant Center is a major organ transplantation program affiliated with the Icahn School of Medicine at Mount Sinai and Mount Sinai Hospital in Manhattan, New York City. The Center provides multidisciplinary care for heart transplantation, lung transplantation, liver transplantation, kidney transplantation, and pancreas transplantation patients, integrating clinical services with research at institutions such as the James J. Peters VA Medical Center and collaborations across the NewYork-Presbyterian Hospital referral network. It participates in national registries and collaborates with agencies including the United Network for Organ Sharing and the National Institutes of Health.

Overview

The Center operates within the broader system of the Mount Sinai Health System, linking clinical programs at Mount Sinai Morningside, Mount Sinai West, Mount Sinai Beth Israel, and The Mount Sinai Hospital Medical Center of New York. Clinical pathways coordinate with specialty services including cardiology units at the Zucker School of Medicine-affiliated sites, pulmonology divisions, and the Department of Surgery at the Icahn School of Medicine. It serves metropolitan and regional populations drawn from New Jersey, Connecticut, Long Island, and interstate referrals from centers such as Cleveland Clinic, Johns Hopkins Hospital, and Mayo Clinic.

History

Transplantation at Mount Sinai traces roots to early 20th-century surgical innovations at Mount Sinai Hospital and the development of immunosuppression following work by researchers at Massachusetts General Hospital and Stanford University School of Medicine. Landmark milestones include the establishment of kidney transplant programs in the 1960s contemporaneous with advances at Harvard Medical School and the first heart and lung programs paralleling efforts at University of Pittsburgh Medical Center. The Center expanded during the 1980s and 1990s amid regulatory changes by the Health Resources and Services Administration and the formation of regional organ procurement organizations such as the New York Organ Donor Network and later the NYC Organ Procurement Organization. Collaborations with Columbia University Vagelos College of Physicians and Surgeons and clinical trial partnerships with Duke University School of Medicine and University of California, San Francisco researchers advanced transplant immunology and antiviral prophylaxis strategies.

Programs and Services

Services include adult and pediatric renal transplantation, simultaneous pancreas-kidney transplantation, orthotopic heart transplantation, bilateral and single-lung transplantation, and combined organ procedures performed in coordination with specialty centers such as the Katz Institute for Women’s Health, Hassenfeld Children’s Hospital at NYU Langone, and the Children’s Hospital of Philadelphia for pediatric referrals. Perioperative support integrates teams from anesthesiology divisions led by faculty with ties to Weill Cornell Medicine and post-transplant care through transplant nephrology, transplant hepatology, and transplant infectious disease clinics collaborating with the Centers for Disease Control and Prevention for infection control. The Center’s outpatient services operate within the Tisch Cancer Institute framework for transplant oncology intersections and coordinate with palliative care teams at Mount Sinai Beth Israel.

Research and Clinical Trials

Research spans transplant immunology, tolerance induction, xenotransplantation research dialogues with groups at Harvard Medical School, cellular therapies aligned with investigators at Stanford and Fred Hutchinson Cancer Research Center, and organ preservation innovations informed by studies at University of Wisconsin. Clinical trials include partnerships with the National Heart, Lung, and Blood Institute, biotech firms headquartered near Cambridge, Massachusetts, and consortiums with Columbia University Irving Medical Center and New York University Grossman School of Medicine. Areas of investigation include desensitization protocols, HLA antibody management pioneered with colleagues from Brigham and Women’s Hospital, mTOR inhibitor studies linked to investigators at University of California, Los Angeles, and antiviral drug trials in collaboration with teams at Mount Sinai Kravis Children’s Hospital and Beth Israel Deaconess Medical Center.

Education and Training

The Center serves as a training site for residents and fellows from the Icahn School of Medicine at Mount Sinai, visiting scholars from Oxford University and Imperial College London, and surgical trainees from programs in partnership with Columbia University and Weill Cornell Medical College. Educational efforts include fellowship programs accredited by relevant American boards, multidisciplinary conferences with faculty from Johns Hopkins University School of Medicine and Stanford University School of Medicine, and CME activities co-sponsored with professional societies such as the American Society of Transplantation and the International Society for Heart and Lung Transplantation. International collaborations extend to transplant centers in Toronto (e.g., University Health Network), Paris institutions like Hôpital Necker–Enfants Malades, and programs at Tokyo Medical and Dental University.

Patient Outcomes and Quality Metrics

The Center reports outcomes to national data systems including the Scientific Registry of Transplant Recipients and meets standards set by the Centers for Medicare & Medicaid Services for transplant programs. Metrics tracked include one-year and five-year graft survival benchmarks compared with peer programs at Cleveland Clinic Foundation, UCLA Health, and Massachusetts General Hospital. Quality initiatives have targeted reductions in rejection rates leveraging protocols developed in collaboration with Fred Hutchinson Cancer Research Center and infection prophylaxis aligned with Johns Hopkins Bloomberg School of Public Health recommendations. Programs also monitor patient-reported outcomes using measures analogous to instruments developed at RAND Corporation and Patient-Centered Outcomes Research Institute.

Notable Physicians and Leadership

Leadership and faculty have included transplant surgeons, cardiologists, nephrologists, and hepatologists who have held appointments or collaborated with institutions such as Yale School of Medicine, Columbia University Vagelos College of Physicians and Surgeons, Harvard Medical School, and Duke University School of Medicine. Notable figures have published alongside investigators from Memorial Sloan Kettering Cancer Center, Rockefeller University, Scripps Research, and Cold Spring Harbor Laboratory on transplantation science, and have participated in advisory roles for organizations like the National Kidney Foundation and the American Heart Association. The Center’s leadership engages with policy forums convened by The White House-led health initiatives and participates in guideline development with the European Society for Organ Transplantation.

Category:Hospitals in Manhattan Category:Transplant centers in the United States